conflicts of interest


What Does Scott Gottlieb’s Leadership Mean for Scientific Integrity at the FDA?

, science and policy analyst, Center for Science and Democracy

Later this afternoon the Senate will vote to confirm Scott Gottlieb as the next U.S. Food and Drug Administration (FDA) commissioner. What does this mean for scientists and science-based policymaking at the FDA? His conflicts of interest are certainly an indication that the pharmaceutical industry will benefit more from his tenure than Americans’ health. Read more >

Bookmark and Share

Advisory Committee Shakeup Targets Independent Science and Scientists

, science and policy analyst, Center for Science and Democracy

There is a full-on assault afoot to strip away the independence of science advisory committees at several government agencies. Read more >

Bookmark and Share

Will Scott Gottlieb Comply with Industry Plea to Stall Added Sugar Label?

, science and policy analyst, Center for Science and Democracy

President Trump’s nominee to head the U.S. Food & Drug Administration (FDA), Scott Gottlieb, faced the Senate in his nomination hearing on Wednesday, during which he implied that delayed implementation of the science-based nutrition facts label revision would be possible if he is confirmed.

Yes, you read that right. Read more >

Bookmark and Share

Advancing Scientific Integrity Through Federal Advisory Committees

, science and policy analyst, Center for Science and Democracy

Back in October, I provided a comment at a public meeting for a National Academies of Science, Engineering and Medicine (NASEM) advisory committee that was set up to review the process to update the Dietary Guidelines for Americans. Their first charge was to write a report with recommendations on how the Dietary Guidelines Advisory Committee (DGAC) selection process could be improved to provide more transparency, minimize bias, and include committee members with a range of viewpoints. Read more >

Bookmark and Share

Rep. Grijalva’s Requests and the Real Problem with Conflict of Interest Disclosure

, Deputy director, Center for Science & Democracy

On Tuesday, Arizona Representative Raul Grijalva asked seven academics for their sources of funding and earlier drafts of testimony they have delivered before congressional committees. Since then, many have debated whether the requests cross the line into harassment or witch hunts or McCarthyism. Lost in the discussion around whether the requests are too broad is a bigger question to address: Why don’t we already know who funds the work of those who testify before Congress? Read more >

Bookmark and Share